- Home
- INBS vs IMCC Comparison
INBS vs IMCC Comparison
Compare INBS & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBS
- IMCC
- Stock Information
- Founded
- INBS 2016
- IMCC 1980
- Country
- INBS United States
- IMCC Israel
- Employees
- INBS N/A
- IMCC N/A
- Industry
- INBS Medical Specialities
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- INBS Health Care
- IMCC Health Care
- Exchange
- INBS Nasdaq
- IMCC Nasdaq
- Market Cap
- INBS 9.6M
- IMCC 10.4M
- IPO Year
- INBS N/A
- IMCC N/A
- Fundamental
- Price
- INBS $1.01
- IMCC $1.41
- Analyst Decision
- INBS
- IMCC
- Analyst Count
- INBS 0
- IMCC 0
- Target Price
- INBS N/A
- IMCC N/A
- AVG Volume (30 Days)
- INBS 376.2K
- IMCC 1.3M
- Earning Date
- INBS 11-07-2025
- IMCC 11-13-2025
- Dividend Yield
- INBS N/A
- IMCC N/A
- EPS Growth
- INBS N/A
- IMCC N/A
- EPS
- INBS N/A
- IMCC N/A
- Revenue
- INBS $3,052,532.00
- IMCC $38,430,631.00
- Revenue This Year
- INBS $778.48
- IMCC $47.12
- Revenue Next Year
- INBS N/A
- IMCC $12.83
- P/E Ratio
- INBS N/A
- IMCC N/A
- Revenue Growth
- INBS N/A
- IMCC 5.08
- 52 Week Low
- INBS $0.92
- IMCC $1.29
- 52 Week High
- INBS $2.75
- IMCC $7.12
- Technical
- Relative Strength Index (RSI)
- INBS 41.15
- IMCC 31.04
- Support Level
- INBS $0.92
- IMCC $1.32
- Resistance Level
- INBS $1.06
- IMCC $2.57
- Average True Range (ATR)
- INBS 0.06
- IMCC 0.23
- MACD
- INBS 0.01
- IMCC -0.04
- Stochastic Oscillator
- INBS 42.86
- IMCC 9.59
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.